These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17327288)

  • 1. Nesiritide compared with milrinone for cardiac surgery.
    Blais DM
    Ann Pharmacother; 2007 Mar; 41(3):502-4. PubMed ID: 17327288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients.
    Brackbill ML; Stam MD; Schuller-Williams RV; Dhavle AA
    Ann Pharmacother; 2007 Mar; 41(3):427-32. PubMed ID: 17311834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of phosphodiesterase III inhibitors: another reason to promote their use?
    Simkova V; Radermacher P; Barth E
    Crit Care; 2007; 11(3):139. PubMed ID: 17572916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination therapy with PDE III inhibitor for heart failure].
    Watanabe H; Kajimoto K; Kawana M
    Nihon Rinsho; 2007 May; 65 Suppl 5():134-9. PubMed ID: 17571377
    [No Abstract]   [Full Text] [Related]  

  • 6. Nesiritide: first use in India.
    Manchanda A; Kohli V
    Indian Heart J; 2009; 61(4):371-2. PubMed ID: 20635741
    [No Abstract]   [Full Text] [Related]  

  • 7. Nesiritide as bridge to multi-organ transplantation: a case report.
    Cochrane AB; Fedson SE; Cronin DC
    Transplant Proc; 2007; 39(1):308-10. PubMed ID: 17275531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of milrinone administrated before weaning from cardiopulmonary bypass in adult cardiac surgery].
    Hibino N; Tomino T; Satoh H; Hamawaki M; Imura M; Suzuki T; Inukai M
    Kyobu Geka; 2000 Nov; 53(12):1019-23. PubMed ID: 11079307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
    Ejaz AA; Martin TD; Johnson RJ; Winterstein AG; Klodell CT; Hess PJ; Ali AK; Whidden EM; Staples NL; Alexander JA; House-Fancher MA; Beaver TM
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):959-64. PubMed ID: 19660420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
    Saltzberg MT
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of nesiritide in pediatric heart failure.
    Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA
    J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary experience with nesiritide in the pediatric population.
    Marshall J; Berkenbosch JW; Russo P; Tobias JD
    J Intensive Care Med; 2004; 19(3):164-70. PubMed ID: 15154997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of phosphodiesterase type III before aortic cross-clamping preserves intramyocardial cyclic adenosine monophosphate during cardiopulmonary bypass.
    Janelle GM; Urdaneta F; Blas ML; Shryock J; Tang YS; Martin TD; Lobato EB
    Anesth Analg; 2001 Jun; 92(6):1377-83. PubMed ID: 11375808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure.
    Gold J; Cullinane S; Chen J; Seo S; Oz MC; Oliver JA; Landry DW
    Am J Cardiol; 2000 Feb; 85(4):506-8, A11. PubMed ID: 10728962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nesiritide in acute heart failure.
    Burger AJ; Silver MA
    Lancet; 2003 Sep; 362(9388):998; author reply 998-9. PubMed ID: 14511939
    [No Abstract]   [Full Text] [Related]  

  • 18. Short and long-term mortality with nesiritide.
    Arora RR; Venkatesh PK; Molnar J
    Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide in acute heart failure.
    Drazner M; McGuire DK; de Lemos JA
    Lancet; 2003 Sep; 362(9388):998-9. PubMed ID: 14511940
    [No Abstract]   [Full Text] [Related]  

  • 20. Natriuretic peptides in the perioperative management of cardiac surgery patients.
    Moazami N; Oz MC
    Heart Surg Forum; 2005; 8(3):E151-7. PubMed ID: 16183564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.